Banerjee A, Talreja A, Li W, Latif F, Ghitelman J, Novarro P, Shirani J, LeJemtel T. Systemic up-regulation of antioxidant defense mechanisms by localized exercise training-an adaptation against oxidative cellular injury. Circulation 2003;108:IV-491. Brofferio A, Oomenn R, Ilercil A, Shirani J. Improved post-exercise detection of tricuspid regurgitation velocity by selecting the optimal image plane from multiple views at baseline. J Invest Med 2003;51 (Supp 2): S366. Brofferio A, Oommen R, Ilercil A, Shirani J. Improved post-exercise detection of tricuspid regurgitant velocity by selecting the optimal image plane from multiple views at the baseline J Invest Med 2003; 51(S2): S366. Dilsizian V, Loredo ML, Jagoda EM, Eckelman WC, Shirani J. Scintigraphic and immunohistochemical evidence for localization of angiotensin converting enzyme to myocytes in human ischemic cardiomyopathy. J Am Coll Cardiol 2003;41:427A. Elmi F, Wood GC, Blankenship JC. N-Acetylcysteine and contrast induces nephropathy in diebetic patients undergoing coronary angiography or intervention. Cathet Cardiovasc Intervent 2003;59:118. (Abstr) Exaire JE, Dauerman HL, Moliterno DJ, Blankenship JC, Hsu A, Raymond RE, Powers ER, Cohen EA, Topol EJ. Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices: results from TARGET. J Am Coll Cardiol 2003:41: 18A. Gavlick K, Blankenship JC, Kleiman NS, Bittl JA, Feit F, Topol EJ, Lincoff AM. Procedural predictors of creatine kinase-MB elevations in the REPLACE-2 study. J Am Coll Cardiol 2004;43:44A (Abstr). Haldis AJ, Blankenship JC. The feasibility of transport for primary PCI in the treatment of STEMI in a rural American setting. J Am Coll Cardiol 2005:45:193A (Abstr). Hamirani KJ, Iliadis EA, Blankenship JC, Aji J. Patent foramen ovale closure in the cardiac catheterization lab: 6 month clinical outcomes and comparison of sizing modalities. . Cathet Cardiovasc Intervent 2003;59:119: B-41. (Abstr) Ilercil A, Brofferio A, Federovich M, Freeman R, Shirani J. Low dose dobutamine mediated brachial artery dilation provides a measure of vascular endothelial function. J Invest Med 2003;51 (Supp 2): S365. Ilercil A, Brofferio A, Feodorovitch M, Freeman R, Shirani J. Low dose dobutamine mediated brachial artery dilation provides a measure of vascular endothelial function. J Invest Med 2003; 51(S2): S365. Ilercil A, Lachmann J, Jones M, Sicilia P, Cesari N, Shirani J, LeJemtel TH. Substantial spontaneous fluctuations in brachial artery flow-mediated dilation despite clinical stability in patients with congestive heart failure. J Invest Med 2003;51 (Supp 2): S365. Iliadis EA, Hamirani KI, Blankenship JC, Aji J. Patent foramen ovale closure in the cardiac catheterization lab; Impact of hypercoagulable state on clinical outcomes for patients undergoing percutaneous closure. Cathet Cardiovasc Intervent 2003;59:119. (Abstr) Kaddissi GI, Topalion SK, Elmi F, Aji J, Blankenship JC, Iliadis EA. Does residual stenosis after beta intravascular brachytherapy predict outcome? . Cathet Cardiovasc Intervent 2003;59:125. (Abstr) Klinger TA, McConnell TR, Cash TL, Monaghan ST. BMI is predictive of decreasing hypoglycemic agents during cardiac rehabilitation. Medicine and Science in Sports and Exercise. 35(5):S173, 2003. McConnell TR, Klinger TA, Boyatzis C. Religiosity and spirituality inversely relates to quality of life and self-efficacy during cardiac rehabilitation. Medicine and Science in Sports and Exercise. 36(5):s237, 2004. McConnell TR, Santamore W, Bove A, Menapace FJ. Patient/provider internet-based telemedicine communication results in increased steps per day and reduced CVD risk. Journal of the American College of Cardiology. 2005. Miller JF, Klinger TA, McConnell TR Spirituality and religiosity: Influence on quality of life and confidence in the patient’s ability to perform physical tasks among spouse caregivers following a first-time cardiac event. Journal of Cardiopulmonary Rehabilitation. 25:299, 2005. Miller K, Sarin S, Blankenship J, McConnell TR. Elevated glucose and hemoglobin A1C at the time of percutaneous coronary intervention affect on one year outcomes. Journal of SCAI. 2005. Mirza A, Al-Sadek M, Iliadis L, Chapman JC, Singh K, Blankenship JC. Does stent expansion to a diameter greater than the adjacent coronary artery contribute to peri-procedural cardiac enzyme elevation? South Med J 2003:10; supplement 45 (Abstr). Puri R, Eisenberg MJ, Blankenship JC, Cugno S, Huynh T. Better functional status among U. S. than non-U. S. patients after percutaneous coronary intervention: an effect of medical care? J Am Coll Cardiol 2003:41: 521A. Shirani J, Loredo ML, Dilsizian V. Evidence for disparate distribution of mast cell chymase and angiotensin converting enzyme in peri-infarct and non-infarct myocardium in ischemic cardiomyopathy. J Invest Med 2003;51 (Supp 2): S366. Shrawder BR, McConnell TR, Santamore W. Pedometer associations with health markers in moderate to high risk patients. Journal of Cardiopulmonary Rehabilitation. 25:298, 2005. Talreja A, Banerjee A, Latif F, Khan Q, Marinaccio M, Klapholz M, Mannino S, Colombo PC, LeJemtel TH, ShiraniJ. Serum B-Type natriuretic peptide levels do not correlate with peak aerobic capacity in chronic heart failure. Circulation 2004;110:III-368-III-369. Vakili A, Babburi H, Ilercil I, Shirani J. Power motion imaging improves assessment of left atrial appendage by transesophageal echocardiography. J Invest Med 2003;51 (Supp 2): S360. Weiss RJ, Auburn ME; Lieux TR, Ahmad M, Shirani J. An open- M Mirza, Singh K, T Scott, BD Fenster, JC Blankenship, JH Chapman, EA Iliadis. Relationship between recurrent chest pain, coronary intervention and lesions with fractional flow reserve (FFR) greater than 0.75. Presented at the Society of Cardiac Angiography &Interventions Annual meeting, Seattle, WA, May 10-12, 2002. M Mirza, Singh K, T. Scott, B Fenster, JC Blankenship, J. Chapman, L. Illiadis. Chest Pain Syndromes persist irrespective of PCI in lesions with Fractional Flow Reserve (FFR) greater than 0.75. Presented at the Society of Cardiac Angiography &Interventions Annual meeting, Seattle, WA, May 10-12, 2002. |
